• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number ERES35038X
Device Problems Burst Container or Vessel (1074); Material Deformation (2976)
Patient Problem No Code Available (3191)
Event Date 12/01/2014
Event Type  Injury  
Event Description
A 3.50 x 38 mm endeavor resolute rx drug-eluting stent was being used to treat a lesion in the mid rca with complete (100%) stenosis.The physician was attempting to direct stent the lesion following thrombus suction.90% stenosis remained after the thrombus suction.It is reported that after positioning stent during balloon inflation the balloon failed to inflate completely, reaching a pressure of 10 atm, and the stent was not opposed to the vessel wall correctly.Inflation was attempted again but a leak was noticed.It is reported that the balloon ruptured at 12 atm.Stent deformation was also noted at this stage.It is reported that the stent was deployed using the original device balloon the patient was sent for emergency cabg procedure.Please note that this device (endeavor resolute) is distributed outside the united states; however, it is similar to the united states distributed product resolute integrity.
 
Manufacturer Narrative
Evaluation, results: failure to follow instructions (direct stenting); patient's condition affected effectiveness of device (90% stenosis); inherent risk of procedure (stent deformation); no results available since no evaluation performed (device not returned for analysis); none (device not returned for analysis).Conclusions: failure to follow instructions (direct stenting); device failure/lack of effectiveness related to patient condition (90% stenosis); inherent risk of procedure (stent deformation); unable to confirm complaint (device not returned for analysis).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RESOLUTE RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key4355731
MDR Text Key20120646
Report Number9612164-2014-01736
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/08/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/09/2016
Device Catalogue NumberERES35038X
Device Lot Number0007220339
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2014
Date Device Manufactured07/10/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00027 YR
Patient Weight70
-
-